Factors associated with permanent pacemaker implantation after tricuspid valve surgery
This study aimed to identify the risk factors associated with permanent pacemaker (PPM) implantation following tricuspid valve (TV) surgery.
Valvulopathies
Impact of tricuspid regurgitation in aortic valve surgery
This retrospective study investigated the prognostic implications of tricuspid regurgitation (TR) in a cohort of 2679 patients who underwent surgical aortic valve replacement (AVR), specifically assessing the potential benefit of concomitant tricuspid valve intervention in those with moderate TR.
Significant mitral regurgitation and mortality: is moderate mitral regurgitation less benign than we think?
This observational study explores the association between mitral regurgitation (MR) severity and both cardiovascular and all-cause mortality.
Clinical surveillance or valve replacement in asymptomatic severe aortic stenosis: the eternal question
A meta-analysis of four randomized controlled trials (RCTs) comparing early aortic valve replacement (either surgical or transcatheter) with a conservative strategy of close clinical surveillance in patients with asymptomatic severe aortic stenosis.
In search of the optimal target population for percutaneous tricuspid valve repair
This multicenter observational study evaluates the impact of percutaneous edge-to-edge tricuspid valve repair on overall survival in patients with tricuspid regurgitation across different disease stages.
Via crucis of TAVI versus surgery in low-risk patients: the three denials
Meta-analysis of the longest available follow-up outcomes from the six main randomized trials comparing TAVI and SAVR in low surgical risk patients in terms of survival and stroke.
Is it possible to reduce the risk of multivalve reoperations?
The Cardiac Surgery team at the Cleveland Clinic (Cleveland, Ohio, USA) reviewed multivalve reoperations (involving more than one valve) performed from 2008 to 2022 and identified the determinants of operative mortality in these procedures.
Safe early discharge after TAVI: is it possible?
A retrospective observational study evaluating patients who underwent TAVI to identify predictive factors for atrioventricular block (AVB) within 24 hours to 30 days post procedure and to develop a risk stratification tool.
Tricuspid regurgitation: guidelines, definitions, and current treatment alternatives. An expert opinion.
Dr. Juan Diego Sánchez’s perspective on the current state of the art in tricuspid regurgitation treatment.
Long-term stroke and mortality risk in nonagenarians after TAVI: does it influence mortality?
This study provides increasingly necessary information to optimize decision-making in a population traditionally underrepresented in TAVI clinical trials: nonagenarian patients.